The Feds Finally Admit That Psychedelics Are Medicine

von pgd | Jan 22, 2020 | International

The heads of the FDA and NIH co-authored a letter acknowledging the therapeutic potential of LSD, MDMA, psilocybin, and ketamine. The heads of the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have acknowledged the therapeutic...

A Single Dose of Psilocybin Mushrooms Can Reduce Anxiety for Nearly Five Years

von pgd | Jan 22, 2020 | Forschung

A 2016 study found that a single dose of shrooms can significantly reduce cancer patients‘ fear of death, and a new follow-up study has found that these benefits can last for years. Nearly five years ago, a team of researchers conducted a landmark trial...

New research confirms lingering mood benefit of psychedelics – Neuroscience News

von pgd | Jan 22, 2020 | Forschung

Summary: Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness after the effect of the drug has worn off. Source: Yale People who had recently used psychedelics such as psilocybin report a sustained improvement in...

Johns Hopkins Scientists Give Psychedelics the Serious Treatment – Scientific American

von pgd | Jan 22, 2020 | International

The first research center of its kind in the country is bringing renewed rigor to the investigation of the drugs’ therapeutic uses. Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been...

scobel – Drogen als Medizin – 3sat-Mediathek

von pgd | Jan 22, 2020 | Aktuelles

Von der illegalen Droge zum Heilmittel: Werden psychedelische Substanzen wie LSD oder „Zauberpilze“ schon bald als Arzneien gegen Depressionen, Angststörungen und Schmerzen eingesetzt? Quelle: scobel – Drogen als Medizin –...

The ethics of psychedelic research in disorders of consciousness

von pgd | Nov 30, 2019 | Forschung

Abstract This article provides an ethical analysis of psychedelic research involving disorders of consciousness patients. We apply two internationally accepted approaches for analyzing the ethics of human research, the Value-Validity Framework and Component Analysis,...

Psychedelic Trauma is Real – K.J. Morris – Medium

von pgd | Nov 30, 2019 | International

Psychedelics are going through a serious revival right now. Clinical trials are taking place with LSD and psilocybin (magic mushrooms), MDMA is already being used to treat PTSD, and ketamine is being prescribed for depression (you’ve probably heard all of this...

Welt im Rausch

von pgd | Nov 30, 2019 | Aktuelles

Steuern wir auf eine Rausch-Gesellschaft zu? Legalisierung wird ein globaler Großtrend – und führt zu einem veränderten Bewusstsein des Selbst und der Gesellschaft. – Ein Auszug aus dem Zukunftsreport 2019. Mehr lesen… Quelle: Welt im Rausch

Toward a contextual psychedelic-assisted therapy: Perspectives from Acceptance and Commitment Therapy and contextual behavioral science – ScienceDirect

von pgd | Nov 30, 2019 | Forschung

Toward a contextual psychedelic-assisted therapy: Perspectives from Acceptance and Commitment Therapy and contextual behavioral science Abstract After two decades of quiescence, clinical psychedelic research re-started in the 1990s and is rapidly accelerating. Early...

Can a Trip-Free Psychedelic Still Help People With Depression? – VICE

von pgd | Nov 30, 2019 | International

Psilocybin has shown promise for conditions like depression. Now, researchers are asking if the psychedelic experience is absolutely necessary to treat mental health. A patient with depression once described their condition as „being enclosed in the most narrow...

The ultimate Psychedelics research review

von pgd | Nov 30, 2019 | Forschung

A comprehensive review of research literature on Psychedelics, for the lay person (2019) In this post you are going to learn everything researchers have discovered to date, on both Psychedelics as well as Non-psychedelic hallucinogens. We’ll share findings in research...

MDMA makes people cooperative, but not gullible

von pgd | Nov 21, 2018 | Forschung

New research from King’s College London has found that MDMA, the main ingredient in ecstasy, causes people to cooperate better—but only with trustworthy people. In the first study to look in detail at how MDMA impacts cooperative behaviour the researchers also...